GI's selection for COVID-19
Molecules | Free Full-Text | Structural Optimization and Structure–Activity Relationship of 4-Thiazolidinone Derivatives as Novel Inhibitors of Human Dihydroorotate Dehydrogenase | HTML
BREQUINAR
ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia | Haematologica
Design, synthesis, molecular modeling, and biological evaluation of acrylamide derivatives as potent inhibitors of human dihydroorotate dehydrogenase for the treatment of rheumatoid arthritis - ScienceDirect
MEDS433 hinders SARS-CoV-2 replication
Design, Synthesis, and Characterization of Brequinar Conjugates as Probes to Study DHODH Inhibition - Madak - 2017 - Chemistry – A European Journal - Wiley Online Library
Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer | Semantic Scholar
Clear Creek Bio doses first patient in Covid-19 trial with brequinar
PDF) Phase I study of Brequinar sodium (NSC 368390) in patients with solid malignancies
Cytotoxicity of brequinar in IBRS-2 cells measured using an MTS assay.... | Download Scientific Diagram
Brequinar sodium (CAS 96201-88-6): R&D Systems
Clear Creek Bio initiates dosing for Covid-19 drug trial
The Dihydroorotate Dehydrogenase Inhibitor Brequinar Is Synergistic with ENT1/2 Inhibitors | ACS Pharmacology & Translational Science
New antiviral drug combination is highly effe | EurekAlert!
The Synergism Between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia | bioRxiv
Clear Creek Bio Announces First Patient Dosed in Clinical Study of Brequinar in Hospitalized Patients with COVID-19 | Business Wire
The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies | Leukemia
Identification of DHODH as a therapeutic target in small cell lung cancer
Inhibition of the mitochondrial pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase by doxorubicin and brequinar sensitizes cancer cells to TRAIL-induced apoptosis | Oncogene
Brequinar - an overview | ScienceDirect Topics
Clear Creek Bio – Brequinar
![PDF] Design, Synthesis, and Characterization of Brequinar Conjugates as Probes to Study DHODH Inhibition. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bd12e06abe9fd076cf2962dc9f8ea31696e542d2/4-Figure2-1.png "PDF] Design, Synthesis, and Characterization of Brequinar Conjugates as Probes to Study DHODH Inhibition. | Semantic Scholar")
PDF] Design, Synthesis, and Characterization of Brequinar Conjugates as Probes to Study DHODH Inhibition. | Semantic Scholar
ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia | Haematologica
